Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
306.4 USD | +0.54% | +0.16% | -1.75% |
Apr. 26 | North American Morning Briefing : Tech Still in -2- | DJ |
Apr. 25 | The specter of stagflation rears its ugly head again |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 28.92 times its estimated earnings per share for the ongoing year.
- With an enterprise value anticipated at 3.71 times the sales for the current fiscal year, the company turns out to be overvalued.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-1.75% | 77.87B | C+ | ||
-16.41% | 32.71B | B- | ||
-12.97% | 30.63B | A- | ||
-13.83% | 14.66B | B | ||
-3.81% | 13.83B | B+ | ||
-16.71% | 7.04B | B | ||
-8.10% | 6.89B | B- | ||
-14.49% | 2.75B | B- | ||
-15.90% | 2.71B | C+ | ||
-30.96% | 2.39B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SHW Stock
- Ratings The Sherwin-Williams Company